Integragen (EURONEXT:ALINT)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ALINT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ALINT

  • Market Cap€15.020m
  • SymbolEURONEXT:ALINT
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINFR0010908723

Company Profile

Integragen is engaged in the development of genetic biomarkers. It offers genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics news, as well as genomic research tools and solutions to microbiologic researchers.Integragen is engaged in Genomic research. It translates molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on its discoveries.

Latest ALINT news

Currently there for this company. Visit our news hub for other news .